Unité de Fabrication des Médicaments S.A (BVMT:UMED)
Tunisia · Delayed Price · Currency is TND 8.48
+0.03 (0.36%)
At close: Sep 12, 2025
BVMT:UMED Revenue
Unité de Fabrication des Médicaments S.A had revenue of 81.46M TND in the half year ending December 31, 2024, with 51.19% growth. This brings the company's revenue in the last twelve months to 153.70M, up 8.91% year-over-year. In the year 2024, Unité de Fabrication des Médicaments S.A had annual revenue of 147.68M with 8.58% growth.
Revenue (ttm)
153.70M
Revenue Growth
+8.91%
P/S Ratio
1.76
Revenue / Employee
268.70K
Employees
572
Market Cap
271.04M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 147.68M | 11.67M | 8.58% |
| Dec 31, 2023 | 136.00M | 39.64M | 41.14% |
| Dec 31, 2022 | 96.36M | 11.85M | 14.02% |
| Dec 31, 2021 | 84.51M | -6.53M | -7.18% |
| Dec 31, 2020 | 91.04M | -16.16M | -15.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition